ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disease Activity"

  • Abstract Number: 583 • 2014 ACR/ARHP Annual Meeting

    What Is the Correlation of Individual HAQ and Basdai Questions with Disease Activity Measures in Ankylosing Spondylitis?  Implications for Instrument Reduction

    Proton Rahman1, Michel Zummer2, Wojciech Olszynski3, Majed Khraishi4, Dalton Sholter5, Rafat Faraawi6, William Bensen7, Milton Baker8, Andrew Chow9, Julie Vaillancourt10, John S. Sampalis10, Francois Nantel11, Allen J Lehman12, Susan Otawa12 and May Shawi11, 1Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 2Université de Montréal, Montreal, QC, Canada, 3University of Saskatchewan, Saskatoon, SK, Canada, 4Nexus Clinical Research, St John's, NF, Canada, 5University of Alberta, Edmonton, AB, Canada, 6McMaster University, Hamilton, ON, Canada, 7Division of Rheumatology, McMaster University, Hamilton, ON, Canada, 8University of Victoria, Victoria, BC, Canada, 9University of Toronto, McMaster University, Credit Valley Rheumatology, Mississauga, ON, Canada, 10JSS Medical Research, Montreal, QC, Canada, 11Janssen Inc., Toronto, ON, Canada, 12Medical Affairs, Janssen Inc., Toronto, ON, Canada

    Background/Purpose Despite the importance of the Health Assessment Questionnaire (HAQ) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in assessing patient-reported functional status and disease…
  • Abstract Number: 369 • 2014 ACR/ARHP Annual Meeting

    Validation of Snapshot, a Rheumatoid Arthritis Assessment Tool, Against CDAI, DAS28 (ESR), and DAS28 (CRP)  in Canadian Patients with Rheumatoid Arthritis

    William G Bensen1, Wynn Bensen2, Melissa Deamude2, Cynthia Mech3, Robert Bensen4, Arthur N. Lau5 and Alpesh Shah6, 1St Josephs Hospital and McMaster University, Hamilton, ON, Canada, 2Dr William G Bensen Medicine Professional Corp, Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, 3Dr. William G. Bensen, Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, 4Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, 5Rheumatology and Clinical Epidemiology, Division of Rheumatology, McMaster University, Hamilton, ON, Canada, 6Epidemiology and Biostatistics, University of Western Ontario, MSc in Clinical Epidemiology, University of Western Ontario, London, ON, Canada

    Background/Purpose: Measuring disease activity in Rheumatoid Arthritis (RA) remains an elusive goal. Both DAS and CDAI have an inherent weakness because similar numbers can result…
  • Abstract Number: 2975 • 2014 ACR/ARHP Annual Meeting

    Residual Large Joint Synovitis By Power Doppler Ultrasonography Is Associated with Higher Disease Activity and Significant Impact of Disease in Multi-Ethnic Asian Patients with Established Rheumatoid Arthritis

    Yu Xiao Guo1, Manjari Lahiri2,3 and Peter Cheung2,3, 1Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 3Division of Rheumatology, National University Hospital, Singapore, Singapore

    Background/Purpose Regular monitoring of disease activity with appropriate modification of disease-modifying anti-rheumatic drug (DMARD) therapy results in improved radiographic and functional outcomes in patients with…
  • Abstract Number: 2578 • 2014 ACR/ARHP Annual Meeting

    Disease Activity Is the Major Determinant of Quality of Life and Physical Function in Patients with Early Axial Spondyloarthritis. Results from the Esperanza Cohort.

    Cristina Fernández-Carballido1, Victoria Navarro-Compán2, Mireia Moreno3, Xavier Juanola4, Juan Mulero5 and Eugenio De Miguel6, 1Rheumatology, University General Hospital Elda, Elda (Alicante), Spain, 2Rheumatology, University Hospital La Paz and Leiden University Medical Center, Madrid, Spain, 3Rheumatology, University Hospital Parc Taulí, Sabadell, Spain, 4Rheumatology, University Hospital Bellvitge, Barcelona, Spain, 5Rheumatology, University Hospital Puerta de Hierro, Majadahonda (Madrid), Spain, 6Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain

    Background/Purpose : Main objective: to describe health related quality of life (HRQoL), physical function (PF) and spinal mobility (SM) in patients with early axial Spondyloarthritis…
  • Abstract Number: 2387 • 2014 ACR/ARHP Annual Meeting

    Relation Between Disease Activity Indices and Their Individual Components and Radiographic Progression in Rheumatoid Arthritis: A Systematic Literature Review

    Victoria Navarro-Compán1, Ana Maria Gherghe2, Josef Smolen3, Daniel Aletaha4, Robert B. M. Landewé5,6 and Désirée van der Heijde7, 1Leiden University Medical Center, Leiden, Netherlands, 2Internal Medicine and Rheumatology, Carol Davila University of Medicine and Pharmacy & Cantacuzino Hospital, Bucharest, Romania, 3Division of Rheumatology, Department of Internal Medicine III,, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, 4Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 5Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 6Atrium Medical Center, Heerlen, Netherlands, 7Dept of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Composite indices and single items are available to monitor disease activity in rheumatoid arthritis (RA). Their relation to radiographic progression is an important aspect…
  • Abstract Number: 1824 • 2014 ACR/ARHP Annual Meeting

    A Randomized Double-Blind Placebo-Controlled Trial of Vitamin D Supplementation in Juvenile-Onset Systemic Lupus Erythematosus: Improvement in Disease Activity and Fatigue Scores

    Glauce Lima, Juliane Paupitz, Liliam Takayama, Eloisa Bonfa and Rosa M R Pereira, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose Vitamin D has an important immunomodulatory effect but there are no clinical trials that directly addressed the benefit from boosting the serum level of…
  • Abstract Number: 1354 • 2014 ACR/ARHP Annual Meeting

    Improving the Measurement of Disease Activity for Patients with Rheumatoid Arthritis: Validation of an Electronic Version of the Routine Assessment of Patient Index Data (RAPID 3)

    Ruthie May Chua1, John Mecchella2,3 and Alicia Zbehlik4,5, 1Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Geisel School of Medicine at Dartmouth, Hanover, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, 5The Geisel School of Medicine at Dartmouth, The Dartmouth Centers for Health and Aging, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH

    Background/Purpose Quantitative measures of disease activity are associated with improved outcomes for patients with rheumatoid arthritis (RA), but many rheumatologists continue to rely on non-quantitative…
  • Abstract Number: 906 • 2014 ACR/ARHP Annual Meeting

    How Long Does Sonographic Joint Activity Continue in Clinically Remittive Joints of Patients with Rheumatoid Arthritis?

    Miriam Gärtner1, Farideh Alasthi2, Gabriela Supp1, Peter Mandl2, Josef Smolen1 and Daniel Aletaha1, 1Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Internal Medicine III, Devision of Rheumatology, Medical University of Vienna, Vienna, Austria

    How long does sonographic joint activity continue in clinically remittive joints of patients with rheumatoid arthritis? M. Gärtner, F. Alasthi, G. Supp, P. Mandl, JS…
  • Abstract Number: 599 • 2014 ACR/ARHP Annual Meeting

    Is There Any Gender Specific Difference in the Cut Off Values of Ankylosing Spondylitis Disease Activity Score (ASDAS) in Patients with Axial Spondyloarthritis?

    Erkan Kilic1, Gamze Kilic1 and Salih Ozgocmen2, 1Division of Rheumatology, Dept. PRM, Erciyes University, Faculty of Medicine, Kayseri, Turkey, 2Division of Rheumatology, Dept.PRM, Erciyes University, Faculty of Medicine, Kayseri, Turkey

    Background/Purpose Axial spondyloarthritis (ax-SpA) consisted patients with advanced axial SpA or ankylosing spondylitis (AS) and non-radiographic axial SpA (nr-axSpA). Evaluation of disease activity in axSpA…
  • Abstract Number: 367 • 2014 ACR/ARHP Annual Meeting

    In Early Rheumatoid Arthritis Patients with Non-Response to Methotrexate Monotherapy the Change in Multi-Biomarker Disease Activity Score Is Differentially Associated with Subsequent Response to Non-Biological Versus Biological Therapy

    Karen Hambardzumyan1, R.J. Bolce2, Saedis Saevarsdottir3, Kristina Forslind4, Ingemar F. Petersson5, Pierre Geborek6, Eric H. Sasso2, David Chernoff2, Scott Cruickshank7 and Ronald F. van Vollenhoven8, 1ClinTRID, the Karolinska Institute, Stockholm, Sweden, 2Crescendo Bioscience Inc., South San Francisco, CA, 3Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Department of Medicine, Karolinska Institute, Stockholm, Sweden, 5Lund University, Lund, Sweden, 6Section of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, 7Scott Cruickshank and Associates, Inc., Santa Barbara, CA, 8Unit for clinical therapy research (ClinTrid), Karolinska Institute, Stockholm, Sweden

    Background/Purpose For patients with early RA (eRA), methotrexate (MTX) is recommended as first-line treatment and in non-responders both the addition of conventional non-biological disease modifying…
  • Abstract Number: 1272 • 2013 ACR/ARHP Annual Meeting

    Whole-Body Versus Thigh Magnetic Resonance Imaging In The Assessment Of Juvenile Dermatomyositis

    Clara Malattia1, Annalisa Madeo2, Marta Dellepiane3, Diliana Beleva3, Stefania Viola4, Alessandro Consolaro5, Nicolino Ruperto1 and Alberto Martini6, 1PRINTO, Genoa, Italy, 2Istituto G Gaslini, Pediatria II, Reumatologia, Genova, Italy, 3Istituto G. Gaslini, Pediatria 2, Genoa, Italy, 4Istituto G. Gaslini, Istituto Giannina Gaslini, Genova, Italy, 5Pediatria II, Istituto Giannina Gaslini, Genova, Italy, 6Istituto Giannina Gaslini, Pediatria II, Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO) Coordinating Center, Genoa, Italy, Genoa, Italy

    Background/Purpose: MRI is a promising tool to assess disease activity in juvenile dermatomyositis (JDM). So far all MRI JDM studies focused on the thigh musculature.…
  • Abstract Number: 468 • 2013 ACR/ARHP Annual Meeting

    The Differential Role Of T Helper Cells In The Pathogenesis and Responsiveness To Abatacept Therapy In Rheumatoid Arthritis

    Shunsuke Fukuyo1, Shingo Nakayamada2, Kunihiro Yamaoka1, Satoshi Kubo1, Shigeru Iwata3, Kazuyoshi Saito1 and Yoshiya Tanaka1, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, Kitakyushu, Japan

    Background/Purpose: Abatacept (ABT) works through a different mechanism of action from TNF inhibitors in the treatment of rheumatoid arthritis (RA). ABT decreases T cell responses…
  • Abstract Number: 2790 • 2013 ACR/ARHP Annual Meeting

    The Research In Arthritis In Canadian Children Emphasizing Outcomes (ReACCh Out) Cohort:  Are We Achieving Clinically Important Outcomes?

    Deborah M. Levy1, Shirley ML Tse1, Elizabeth Stringer2, Jaime Guzman3, Roberta A. Berard4, Karen Watanabe Duffy5, Dax Rumsey1, Mercedes O. Chan3, Rosie Scuccimarri6, Adam M. Huber7, Lori B. Tucker3, Rae SM Yeung1, Ciaran M. Duffy5, Kiem Oen8 and The ReACCh Out Investigators9, 1Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 2Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 3Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 4Children's Hospital of Western Ontario, London, ON, Canada, 5Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 6McGill University, Montreal, QC, Canada, 7Dalhousie University, Halifax, NS, Canada, 8Pediatrics, Children's Hospital of Winnipeg and University of Manitoba, Winnipeg, MB, Canada, 9The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada

    Background/Purpose:  Recent data suggests that achievement of inactive disease and early disease remission may result in improved outcomes for patients with juvenile idiopathic arthritis (JIA). …
  • Abstract Number: 2272 • 2013 ACR/ARHP Annual Meeting

    Patient Survey Regarding Utility Of The Health Assessment Questionnaire Reveals An Unrecognized Aspect Of Disease Activity In Rheumatoid Arthritis: Consequences Of Physical Activity

    Kelly O'Neill Young1, Dana M. Symons1, Andrew T. Lumpe2 and Cynthia S. Crowson3, 1Rheumatoid Patient Foundation, Cocoa, FL, 2Seattle Pacific University, Seattle, WA, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Patient Survey Regarding Utility of the Health Assessment Questionnaire Reveals an Unrecognized Aspect of Disease Activity in Rheumatoid Arthritis: Consequences of Physical Activity Background/Purpose: The…
  • Abstract Number: 1948 • 2013 ACR/ARHP Annual Meeting

    Power Doppler Ultrasound 7-Joint Score Vs. Simplified Disease Activity Index In Rheumatoid Arthritis Associated With Fibromyalgia

    Rafael Chakr1, Marina Behar2, José A. Mendonça3, Daniela Cervantes2, Nizele Calegaro2, Nicole Andrade2, Iuri Siqueira2, Daniel Zanchet2, Andrese Gasparin2, Penélope Esther Palominos2, Charles Kohem4, Odirlei Andre Monticielo5, Claiton Brenol6, Ricardo M. Xavier2 and João Carlos T. Brenol7, 1Rheumatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 2Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 3Rheumatology, Pontifical Catholic University of Campinas / Institute of Clinical Research – IPECC, Campinas, Brazil, 4Brazilian Registry of Spondyloarthritis, São Paulo, Brazil, 5Department of Internal Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 6Universidade Federal do Rio Grande do Sul, Porto Alegre RS, Brazil, 7Rheumatology Division, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

    Background/Purpose: Fibromyalgia (FM) falsely increases rheumatoid arthritis (RA) disease activity clinical composite scores, such as the simplified disease activity index (SDAI), recently incorporated into ACR/EULAR…
  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 102
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology